Obesity and GLP-1 RAs.

Bright, Tamis

Bright, Tamis.

Bright T; Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA tamis.bright@ttuhsc.edu.

J Investig Med ; 70(1): 1-2, 2022 01.

Article in English | MEDLINE | ID: covidwho-1591930

Subject(s)

Anti-Obesity Agents/therapeutic use; Glucagon-Like Peptide-1 Receptor/therapeutic use; Obesity/therapy; Diabetes Mellitus, Type 2/drug therapy; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents/therapeutic use

Keywords

glucagon-like peptide 1; obesity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Obesity Agents / Glucagon-Like Peptide-1 Receptor / Obesity Limits: Humans Language: English Journal: J Investig Med Journal subject: Medicine Year: 2022 Document Type: Article Affiliation country: Jim-2021-002268

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google